Vimarsana
Biggest News Aggregation in the World

Page 32 - Evercore Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evercore Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evercore Group Today - Breaking & Trending Today

PDVSA's supervising board to appeal new creditors' move to go after Citgo - Vimarsana News

PDVSA's supervising board to appeal new creditors' move to go after Citgo

A board that supervises Venezuela's overseas assets said it plans to file an appeal to a U.S. court's decision granting four firms the right to seize shares in one of the parent companies of Venezuela-owned U.S. refiner Citgo Petroleum.

PDVSA's supervising board to appeal new creditors' move to go after Citgo - Vimarsana News

PDVSA's supervising board to appeal new creditors' move to go after Citgo

A board that supervises Venezuela's overseas assets said it plans to file an appeal to a U.S. court's decision granting four firms the right to seize shares in one of the parent companies of Venezuela-owned U.S. refiner Citgo Petroleum.

Yak Access Completes Comprehensive Recapitalization and Exchange Transaction - Vimarsana News

Yak Access Completes Comprehensive Recapitalization and Exchange Transaction

/PRNewswire/ -- Yak Access, LLC ("Yak" or the "Company"), the nation's leading provider of temporary access roads and related services, has announced that it...

StockWatch: Apellis Wows Analysts with First FDA Approval for GA Therapy - Vimarsana News

StockWatch: Apellis Wows Analysts with First FDA Approval for GA Therapy

Nine analysts raise stock price targets for Apellis Pharmaceuticals after it wins the FDA's first approval for a geographic atrophy therapy.

Apellis Pharmaceuticals Announces Closing of Public - Vimarsana News

Apellis Pharmaceuticals Announces Closing of Public

WALTHAM, Mass., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc., (Nasdaq: APLS), a global biopharmaceutical company and leader in...